Gladskin

Gladskin's mission is to improve the lives of people with inflammatory skin conditions. The company is revolutionizing skincare and reimagining treatment approaches by focusing on the next major frontier in human health: the microbiome.The company uses endolysins in its products to address inflammatory skin conditions. Gladskin is a subsidiary of European biotech company Micreos, which is developing sustainable alternatives to antibiotics to tackle the global issue of antibiotic resistance.